GlassScriptPhysician profile
Brandy M Tonini
NPI 1295217024
$925.99
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $826 · 2022: $100.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $251.20 | 2021 | |
| Indivior INC. | $115.73 | 2021 | |
| Lilly USA, LLC | $102.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $97.50 | 2021 | |
| Organon LLC | $86.57 | 2022 | |
| Amarin Pharma, INC. | $50.30 | 2021 | |
| Glaxosmithkline, LLC. | $46.97 | 2021 | |
| Pfizer INC. | $46.72 | 2021 | |
| Novo Nordisk INC | $28.51 | 2021 | |
| Nestle Healthcare Nutrition INC. | $20.42 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.21 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.32 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.56 | 2021 | |
| Therapeuticsmd, INC. | $13.92 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.29 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Tonini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.